Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription 06.05.2024 1 Am J Hypertens 1 Biochem Biophys Res Commun 1 BMJ 2 Circulation 4 Hypertension 1 J Am Coll Cardiol 1 J Diabetes Complications 2 J Hum Hypertens 26 J Hypertens 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hypertens

1. VAN DER STOUWE JG, Rossi VA, Ghidoni C, Wurzburger L, et al
   Effect of a hypertensive response during exercise on growth rates of aortic diameters.
   Am J Hypertens. 2024 May 2:hpae050. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. PETER JK, Umene R, Wu CH, Nakamura Y, et al
   Renal macrophages induce hypertension and kidney fibrosis in Angiotensin II salt mice model.
   Biochem Biophys Res Commun. 2024;715:149997.
   PubMed         Abstract available
   
   

   
   BMJ

3. ROBINSON A
   The risk of falls in older people prescribed antihypertensives ... and other research.
   BMJ. 2024;385:q970.
   PubMed        
   
   

   
   Circulation

4. TANG H, Gupta A, Morrisroe SA, Bao C, et al
   Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
   Circulation. 2024 May 2. doi: 10.1161/CIRCULATIONAHA.123.065304.
   PubMed         Abstract available
   
   
5. BORDAN Z, Batori R, Haigh S, Li X, et al
   PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.
   Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095.
   PubMed         Abstract available
   
   

   
   Hypertension

6. ARIF Y, Killanin AD, Zhu J, Willett MP, et al
   Hypertension Impacts the Oscillatory Dynamics Serving the Encoding Phase of Verbal Working Memory.
   Hypertension. 2024 May 1. doi: 10.1161/HYPERTENSIONAHA.124.22698.
   PubMed         Abstract available
   
   
7. YE D, Cruz-Lopez EO, Veghel RV, Garrelds IM, et al
   Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR.
   Hypertension. 2024 May 1. doi: 10.1161/HYPERTENSIONAHA.124.22878.
   PubMed         Abstract available
   
   
8. FOTI K, Wang D, Tang O, Daya NR, et al
   Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.
   Hypertension. 2024 May 1. doi: 10.1161/HYPERTENSIONAHA.123.22665.
   PubMed         Abstract available
   
   
9. DOS PASSOS RR JR, Santos CV, Priviero F, Briones AM, et al
   Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective.
   Hypertension. 2024 Apr 30. doi: 10.1161/HYPERTENSIONAHA.124.21712.
   PubMed         Abstract available
   
   

   
   J Am Coll Cardiol

10. OU YH, Colpani JT, Cheong CS, Loke W, et al
    Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients With Obstructive Sleep Apnea.
    J Am Coll Cardiol. 2024;83:1760-1772.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

11. BOOKER R, Wong M, Bancks MP, Carnethon MR, et al
    The longitudinal association of adipose-to-lean ratio with incident cardiometabolic morbidity: The CARDIA study.
    J Diabetes Complications. 2024;38:108725.
    PubMed         Abstract available
    
    

    
    J Hum Hypertens

12. GAFANE-MATEMANE LF, Craig A, Kruger R, Alaofin OS, et al
    Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities.
    J Hum Hypertens. 2024 May 2. doi: 10.1038/s41371-024-00913.
    PubMed         Abstract available
    
    
13. NEYAZI A, Mohammadi AQ, Neyazi M, Timilsina S, et al
    Hypertension, depression, and health-related quality of life among hospitalized patients in Afghanistan.
    J Hum Hypertens. 2024 Apr 29. doi: 10.1038/s41371-024-00914.
    PubMed         Abstract available
    
    

    
    J Hypertens

14. ZHOU YF, Ye YX, Chen JX, Zhang YB, et al
    Circulating metabolic biomarkers and risk of new-onset hypertension: findings from the UK Biobank.
    J Hypertens. 2024;42:1066-1074.
    PubMed         Abstract available
    
    
15. CAMARGO LL, Trevelin SC, da Silva GHG, Dos Santos Dias AA, et al
    Protein disulfide isomerase-mediated transcriptional upregulation of Nox1 contributes to vascular dysfunction in hypertension.
    J Hypertens. 2024;42:984-999.
    PubMed         Abstract available
    
    
16. KREUTZ R, Brunstrom M, Burnier M, Grassi G, et al
    Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern.
    J Hypertens. 2024;42:966-967.
    PubMed        
    
    
17. CHARCHAR FJ
    Wake up and enjoy the coffee without worrying about your blood pressure!
    J Hypertens. 2024;42:965.
    PubMed        
    
    
18. LATOSINSKA A, Siwy J, Mischak H
    Multiomics: paving the path towards personalized prevention of hypertension.
    J Hypertens. 2024;42:962-964.
    PubMed        
    
    
19. RUILOPE LM
    Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'.
    J Hypertens. 2024;42:961.
    PubMed        
    
    
20. BERSCH-FERREIRA AC, Machado RHV, de Oliveira JS, Santos RHN, et al
    Effectiveness of a two-component nutritional strategy for blood pressure control in individuals with hypertension users of a public health system: a randomized controlled clinical trial.
    J Hypertens. 2024 Feb 26. doi: 10.1097/HJH.0000000000003703.
    PubMed         Abstract available
    
    
21. GUO J, Jia P, Gu Z, Tang W, et al
    Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003716.
    PubMed         Abstract available
    
    
22. CHE J, Tong J, Kuang X, Zheng C, et al
    Hyperuricemia and gout enhanced the risk of long-term mortality in hypertension: insights from the National Health and Nutrition Examination Survey 2007-2018.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003744.
    PubMed         Abstract available
    
    
23. TREVANO FQ, Vela-Bernal S, Facchetti R, Cuspidi C, et al
    Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study.
    J Hypertens. 2024;42:1094-1100.
    PubMed         Abstract available
    
    
24. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
    Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
    J Hypertens. 2024;42:1009-1018.
    PubMed         Abstract available
    
    
25. KOKKO E, Choudhary MK, Mutanen A, Honkonen M, et al
    Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study.
    J Hypertens. 2024;42:1057-1065.
    PubMed         Abstract available
    
    
26. VRIEND EMC, Bouwmeester TA, Franco OH, Galenkamp H, et al
    Sex differences in blood pressure phenotypes over time - the HELIUS study.
    J Hypertens. 2024;42:977-983.
    PubMed         Abstract available
    
    
27. THOMOPOULOS C, Hitij JB, De Backer T, Gkaliagkousi E, et al
    Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003739.
    PubMed         Abstract available
    
    
28. HUA D, Huang W, Huang W, Xie Q, et al
    TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
    J Hypertens. 2024 May 2. doi: 10.1097/HJH.0000000000003748.
    PubMed         Abstract available
    
    
29. KYRIAKOULIS KG, Kollias A, Bilo G, Soranna D, et al
    Blood pressure variability assessed by office, home, and ambulatory measurements before and during antihypertensive drug treatment: a sub-analysis of the REVERENT randomized trial.
    J Hypertens. 2024 Apr 5. doi: 10.1097/HJH.0000000000003730.
    PubMed         Abstract available
    
    
30. XU ZQ, Li XZ, Zhu R, Ge R, et al
    Asprosin contributes to vascular remodeling in hypertensive rats via superoxide signaling.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003751.
    PubMed         Abstract available
    
    
31. WANG Z, Li W, Jiang C, Wang J, et al
    Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003715.
    PubMed         Abstract available
    
    
32. FARAH BQ, Forjaz CLM, O'Driscoll JM, Millar PJ, et al
    Characteristics associated with responsiveness to isometric handgrip training in medicated hypertensive patients: secondary data analysis.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003749.
    PubMed         Abstract available
    
    
33. PALERMITI A, Pappaccogli M, Rabbia F, D'Avolio A, et al
    Multiple drug intolerance in antihypertensive patients: what is known and what is missing.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003737.
    PubMed         Abstract available
    
    
34. MAVROGEORGIS E, Kondyli M, Mischak H, Vlahou A, et al
    Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
    J Hypertens. 2024 Mar 29. doi: 10.1097/HJH.0000000000003726.
    PubMed         Abstract available
    
    
35. WU J, Wu Z, Kuang W, Shi D, et al
    Combined vaccines against angiotensin II receptor type 1 and alpha 1D-adrenergic receptor for hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003710.
    PubMed         Abstract available
    
    
36. 
    Dietary factors and hypertension risk in West Africa: a systematic review and meta-analysis of observational studies: Erratum.
    J Hypertens. 2024;42:1108.
    PubMed        
    
    
37. PEETERS LEJ, Koch BCP, Versmissen J
    Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.
    J Hypertens. 2024;42:1106-1107.
    PubMed        
    
    
38. RUBIN D, Lo DF, Jammula S, Carroll N, et al
    Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
    J Hypertens. 2024;42:1105-1106.
    PubMed        
    
    
39. MINETTO J, Cuello MB, Dominici FP, Caniffi C, et al
    Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension.
    J Hypertens. 2024;42:1101-1104.
    PubMed         Abstract available
    
    

    
    PLoS One

40. LAL D, Virk AK, Bhardwaj A, Lal KK, et al
    Pestilent relationship between smoking and hypertension or pulse pressure among males over 15 years in India: NFHS-5 Survey.
    PLoS One. 2024;19:e0294898.
    PubMed         Abstract available
    
    
41. ADU-GYAMFI R, Enos J, Yeboah K, Shabanova V, et al
    Screening for Hypertension in adolescents living with HIV: Protocol for a cluster randomized trial to improve guideline adherence.
    PLoS One. 2024;19:e0302016.
    PubMed         Abstract available
    
    
42. 
    Correction: Consideration of body mass index (BMI) in the association between hand grip strength and hypertension: Korean Longitudinal Study of Ageing (KLoSA).
    PLoS One. 2024;19:e0303220.
    PubMed         Abstract available
    
    
43. WELCH TR, Yaqub A, Aiti D, Prevedello LM, et al
    Quantifying effects of blood pressure control on neuroimaging utilization in a large multi-institutional healthcare population.
    PLoS One. 2024;19:e0298685.
    PubMed         Abstract available
    
    
44. BOOCKVAR KS, Huan T, Curyto K, Lee S, et al
    Increase in blood pressure precedes distress behavior in nursing home residents with dementia.
    PLoS One. 2024;19:e0298281.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.